BE880830A - Medicament a prise orale a action d'inhibition de l'inflammation - Google Patents

Medicament a prise orale a action d'inhibition de l'inflammation Download PDF

Info

Publication number
BE880830A
BE880830A BE198724A BE198724A BE880830A BE 880830 A BE880830 A BE 880830A BE 198724 A BE198724 A BE 198724A BE 198724 A BE198724 A BE 198724A BE 880830 A BE880830 A BE 880830A
Authority
BE
Belgium
Prior art keywords
oral medicine
inhibition action
inflammation inhibition
inflammation
action
Prior art date
Application number
BE198724A
Other languages
English (en)
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of BE880830A publication Critical patent/BE880830A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE198724A 1978-12-27 1979-12-21 Medicament a prise orale a action d'inhibition de l'inflammation BE880830A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2856333A DE2856333C2 (de) 1978-12-27 1978-12-27 Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Publications (1)

Publication Number Publication Date
BE880830A true BE880830A (fr) 1980-04-16

Family

ID=6058494

Family Applications (1)

Application Number Title Priority Date Filing Date
BE198724A BE880830A (fr) 1978-12-27 1979-12-21 Medicament a prise orale a action d'inhibition de l'inflammation

Country Status (13)

Country Link
US (1) US4332795A (fr)
JP (1) JPS5589225A (fr)
AT (1) AT369654B (fr)
BE (1) BE880830A (fr)
CA (1) CA1133395A (fr)
CH (1) CH643739A5 (fr)
DE (1) DE2856333C2 (fr)
FR (1) FR2445146A1 (fr)
GB (1) GB2039738B (fr)
IT (1) IT1164550B (fr)
NL (1) NL7909244A (fr)
SE (1) SE448603B (fr)
ZA (1) ZA797008B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026889A1 (fr) * 1996-01-22 1997-07-31 The University Of New England Procede et composition de potentialisation de medicaments anti-inflammatoires

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease
GB2119244A (en) * 1982-04-30 1983-11-16 Alza Corp Potassium replacement therapy
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
CA1237670A (fr) * 1983-05-26 1988-06-07 Andrew S. Janoff Reduction de la toxicite de certains medicaments
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5091187A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
AU709262B2 (en) * 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
WO1999040906A2 (fr) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Procede et composition de traitement d'etats inflammatoires
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
RU2233654C2 (ru) 1998-11-20 2004-08-10 Ртп Фарма Инк. Диспергируемые стабилизированные фосфолипидом микрочастицы
IL148685A0 (en) * 1999-09-21 2002-09-12 Rtp Pharma Inc Surface modified particulate compositions of biologically active substances
ES2469642T3 (es) 2000-04-20 2014-06-18 Jagotec Ag Procedimiento mejorado para partículas de fármaco insoluble en agua
US6634576B2 (en) 2000-08-31 2003-10-21 Rtp Pharma Inc. Milled particles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
ES2372746T3 (es) * 2000-09-20 2012-01-26 Jagotec Ag Micropartículas de fibrato estabilizadas.
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
WO2002067901A1 (fr) * 2001-02-22 2002-09-06 Skyepharma Canada Inc. Combinaisons statine et fibrate presentant des effets secondaires alimentaires indesirables « a jeun-nourri » reduits
AU2012315545B2 (en) 2011-09-29 2017-03-09 Plx Opco Inc. pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
JP6103143B1 (ja) * 2015-05-18 2017-03-29 不二製油株式会社 ＩＬ−１β産生抑制作用を有する食品添加用組成物
CA3172595A1 (fr) 2020-03-26 2021-09-30 Ronald Zimmerman Supports pharmaceutiques aptes a la reconstitution dependante du ph et leurs procedes de fabrication et d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL32337C (fr) *
IT1044768B (it) * 1969-04-03 1980-04-21 Italeapmaco Spa Supposte contenenti un principio attivo ascorbato di aminofemazione liofilizzato e processo per la loro preparazione

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026889A1 (fr) * 1996-01-22 1997-07-31 The University Of New England Procede et composition de potentialisation de medicaments anti-inflammatoires

Also Published As

Publication number Publication date
JPS5589225A (en) 1980-07-05
JPS6320209B2 (fr) 1988-04-26
DE2856333C2 (de) 1983-09-22
DE2856333A1 (de) 1980-08-21
AT369654B (de) 1983-01-25
GB2039738A (en) 1980-08-20
ATA808379A (de) 1982-06-15
IT7928358A0 (it) 1979-12-21
FR2445146A1 (fr) 1980-07-25
ZA797008B (en) 1980-12-31
SE7910371L (sv) 1980-06-28
US4332795A (en) 1982-06-01
IT1164550B (it) 1987-04-15
CA1133395A (fr) 1982-10-12
CH643739A5 (de) 1984-06-29
FR2445146B1 (fr) 1983-09-02
GB2039738B (en) 1983-04-13
NL7909244A (nl) 1980-07-01
SE448603B (sv) 1987-03-09

Similar Documents

Publication Publication Date Title
BE880830A (fr) Medicament a prise orale a action d'inhibition de l'inflammation
BE879918A (fr) Distributeur de medicament
DK153631C (da) Medikamentdispenser
NO149531C (no) Administreringssett
AR219000A1 (es) Conjunto de cateter intravenoso
GB2014953B (en) Intravenous administration set
BR7906446A (pt) Conjunto de cateter intravenoso
BE879187A (nl) Wegwerpcatheter
GR64905B (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
AU521053B2 (en) Medicament dosage form
JPS55147223A (en) Pharmaceutical medicine
IT7819512A0 (it) Copolieteresterammidi stabili all'idrolisi.
ZA794124B (en) Anti-inflammatory agents including 2-carbonyl-3-hydroxy-2-alkenonitriles
BE867576A (fr) Matieres d'obturation dentaires
IT1110787B (it) Dispositivo perfezionato per l'applicazione di un catetere
FR2297890A1 (fr) Polyesters resistant a l'inflammation
FI56873B (fi) Med formkuggar foersedd valskonstruktion foer avfallskrossanordning avsedd foer avstjaelpningsplatser
IT7927142A0 (it) Copoliesteri di-p-ossibenzoile a flessibilita' e solubilita'migliorate.
PT69674A (pt) Procede de preparation d'un medicament contre les maladiesinfectieuses des voies respiratoires
BR7603696A (pt) Aparelho para introducao de uma materia atuante sobre plantas em uma corrente d'agua respectivamente em agua de regadio
GB2039739B (en) Medicament against glaucoma
ZA794581B (en) N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
IT7831198A0 (it) Derivato isossazolico,ad attivita'terapeutica
IT7819818A0 (it) Dispositivo per arrestare il rotore di un dispositivo di filatura adestremita' aperta.
IT7851317A0 (it) Composizione orale ad azione antitartaro